Hua Medicine Successfully Completes Its Registration Phase III Trials; Announces 52-Week Results for DAWN (HMM0302), Dorzagliatin's Phase III Combination with Metformin Trial
- Written by ACN Newswire - Press Releases
- Successfully completes two Phase III 53-week registration trials in over 1,200+ Chinese patients in the midst of
Read more //?#